190 related articles for article (PubMed ID: 25843361)
1. Thirty years through vanadium chemistry.
Costa Pessoa J
J Inorg Biochem; 2015 Jun; 147():4-24. PubMed ID: 25843361
[TBL] [Abstract][Full Text] [Related]
2. Preface: Celebrating vanadium science with leading bioinorganic contributions from the 9th International Vanadium Symposium.
Crans DC; Ghio A; Conte V
J Inorg Biochem; 2015 Jun; 147():1-3. PubMed ID: 26077794
[No Abstract] [Full Text] [Related]
3. Design, synthesis and characterization of novel binary V(V)-Schiff base materials linked with insulin-mimetic vanadium-induced differentiation of 3T3-L1 fibroblasts to adipocytes. Structure-function correlations at the molecular level.
Halevas E; Tsave O; Yavropoulou MP; Hatzidimitriou A; Yovos JG; Psycharis V; Gabriel C; Salifoglou A
J Inorg Biochem; 2015 Jun; 147():99-115. PubMed ID: 25920352
[TBL] [Abstract][Full Text] [Related]
4. Oligonuclear Actinoid Complexes with Schiff Bases as Ligands-Older Achievements and Recent Progress.
Tsantis ST; Tzimopoulos DI; Holynska M; Perlepes SP
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31952278
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of oxovanadium(IV) complexes of Schiff-base condensates from 5-substituted-2-hydroxybenzaldehyde and 2-substituted-benzenamine as selective inhibitors of protein tyrosine phosphatase 1B.
Han H; Lu L; Wang Q; Zhu M; Yuan C; Xing S; Fu X
Dalton Trans; 2012 Aug; 41(36):11116-24. PubMed ID: 22864521
[TBL] [Abstract][Full Text] [Related]
6. Antidiabetic, Chemical, and Physical Properties of Organic Vanadates as Presumed Transition-State Inhibitors for Phosphatases.
Crans DC
J Org Chem; 2015 Dec; 80(24):11899-915. PubMed ID: 26544762
[TBL] [Abstract][Full Text] [Related]
7. Medicinal applications of vanadium complexes with Schiff bases.
Hashmi K; Satya ; Gupta S; Siddique A; Khan T; Joshi S
J Trace Elem Med Biol; 2023 Sep; 79():127245. PubMed ID: 37406475
[TBL] [Abstract][Full Text] [Related]
8. Is vanadate reduced by thiols under biological conditions? Changing the redox potential of V(V)/V(IV) by complexation in aqueous solution.
Crans DC; Zhang B; Gaidamauskas E; Keramidas AD; Willsky GR; Roberts CR
Inorg Chem; 2010 May; 49(9):4245-56. PubMed ID: 20359175
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization, single crystal X-ray determination, fluorescence and electrochemical studies of new dinuclear nickel(II) and oxovanadium(IV) complexes containing double Schiff base ligands.
Shafaatian B; Ozbakzaei Z; Notash B; Rezvani SA
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Apr; 140():248-55. PubMed ID: 25613693
[TBL] [Abstract][Full Text] [Related]
10. Aqueous vanadium ion dynamics relevant to bioinorganic chemistry: A review.
Kustin K
J Inorg Biochem; 2015 Jun; 147():32-8. PubMed ID: 25578410
[TBL] [Abstract][Full Text] [Related]
11. Correlations between (51)V solid-state NMR parameters and chemical structure of vanadium (V) complexes as models for related metalloproteins and catalysts.
Fenn A; Wächtler M; Gutmann T; Breitzke H; Buchholz A; Lippold I; Plass W; Buntkowsky G
Solid State Nucl Magn Reson; 2009 Dec; 36(4):192-201. PubMed ID: 20045295
[TBL] [Abstract][Full Text] [Related]
12. The future of/for vanadium.
Rehder D
Dalton Trans; 2013 Sep; 42(33):11749-61. PubMed ID: 23567506
[TBL] [Abstract][Full Text] [Related]
13. In vitro antibacterial, antifungal and cytotoxic activities of some triazole Schiff bases and their oxovanadium(IV) complexes.
Sumrra SH; Chohan ZH
J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1291-9. PubMed ID: 23116556
[TBL] [Abstract][Full Text] [Related]
14. The (biological) speciation of vanadate(V) as revealed by (51)V NMR: A tribute on Lage Pettersson and his work.
Rehder D
J Inorg Biochem; 2015 Jun; 147():25-31. PubMed ID: 25592749
[TBL] [Abstract][Full Text] [Related]
15. Vanadium complexes having [V(IV)O](2+) and [V(V)O(2)](+) cores with binucleating dibasic tetradentate ligands: Synthesis, characterization, catalytic and antiamoebic activities.
Maurya MR; Khan AA; Azam A; Ranjan S; Mondal N; Kumar A; Avecilla F; Pessoa JC
Dalton Trans; 2010 Feb; 39(5):1345-60. PubMed ID: 20104362
[TBL] [Abstract][Full Text] [Related]
16. Stereospecificity in vanadium Schiff base complexes: Formation, crystallization and epimerization processes.
Krivosudský L; Schwendt P; Šimunek J; Gyepes R
J Inorg Biochem; 2015 Jun; 147():65-70. PubMed ID: 25680458
[TBL] [Abstract][Full Text] [Related]
17. Aqueous chemistry of the vanadium(III) (V(III)) and the V(III)-dipicolinate systems and a comparison of the effect of three oxidation states of vanadium compounds on diabetic hyperglycemia in rats.
Buglyó P; Crans DC; Nagy EM; Lindo RL; Yang L; Smee JJ; Jin W; Chi LH; Godzala Iii ME; Willsky GR
Inorg Chem; 2005 Jul; 44(15):5416-27. PubMed ID: 16022540
[TBL] [Abstract][Full Text] [Related]
18. Sarcoplasmic reticulum calcium ATPase is inhibited by organic vanadium coordination compounds: pyridine-2,6-dicarboxylatodioxovanadium(V), BMOV, and an amavadine analogue.
Aureliano M; Henao F; Tiago T; Duarte RO; Moura JJ; Baruah B; Crans DC
Inorg Chem; 2008 Jul; 47(13):5677-84. PubMed ID: 18510311
[TBL] [Abstract][Full Text] [Related]
19. Vanadium(V) complex with Schiff-base ligand containing a flexible amino side chain: Synthesis, structure and reactivity.
Nica S; Rudolph M; Lippold I; Buchholz A; Görls H; Plass W
J Inorg Biochem; 2015 Jun; 147():193-203. PubMed ID: 25747149
[TBL] [Abstract][Full Text] [Related]
20. Metal based biologically active compounds: design, synthesis, and antibacterial/antifungal/cytotoxic properties of triazole-derived Schiff bases and their oxovanadium(IV) complexes.
Chohan ZH; Sumrra SH; Youssoufi MH; Hadda TB
Eur J Med Chem; 2010 Jul; 45(7):2739-47. PubMed ID: 20338672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
